NEXIUM® I.V. (esomeprazole sodium) is the first proton pump inhibitor (PPI) approved for children 1 month old or greater. NEXIUM I.V. for Injection is approved for patients greater than 1 month old for the short-term treatment of gastroesophageal reflux disease (GERD) with erosive esophagitis when oral therapy is not possible or appropriate.1
NEXIUM I.V. is approved for more patients than any other I.V. PPI
1. NEXIUM I.V. Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.